Catheter Precision, Inc. Announces the Presentation of the First Clinical Data on LockeTAccesswire • 02/22/24
Catheter Precision, Inc. (NYSE American:VTAK) Presenting at the Sequire Investor Summit in Puerto RicoAccesswire • 01/22/24
CORRECTION: Catheter Precision, Inc.'s (VTAK) Board Authorizes its CEO and Chairman to Make "Open Market" Purchases of Company SharesAccesswire • 01/11/24
Cather Precision, Inc.'s (VTAK) Board Authorizes its CEO and Chairman to Make "Open Market" Purchases of Company SharesAccesswire • 01/11/24
CATHETER PRECISION, INC. (VTAK) Reports Unaudited Preliminary Fourth Quarter and Full Year 2023 ResultsAccesswire • 01/10/24
Catheter Precision, Inc. (VTAK) Announces Changes to Executive Management and Board of DirectorsAccesswire • 01/03/24
Catheter Precision, Inc. (VTAK) Receives Additional Patents for LockeT in Great Britain and the European MarketAccesswire • 01/02/24
Catheter Precision, Inc. Reports Third Quarter Results of Operations and Filing of Third Quarter 10-QAccesswire • 12/22/23
CATHETER PRECISION, INC. Reports Filing of 10-Q and Second Quarter Results of OperationsAccesswire • 12/18/23
Catheter Precision, Inc. (NYSE American:VTAK) Presenting at the Emerging Growth Conference on December 6, 2023Accesswire • 12/05/23
Catheter Precision's (VTAK) First Successful VIVO(TM) Cases Completed in Croatia Sets Stage for Expansion into South-Eastern EuropeAccesswire • 11/20/23
Catheter Precision, Inc. to Participate in the H.C. Wainwright 25th Annual Global Investment ConferenceAccesswire • 09/07/23
Catheter Precision Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-QAccesswire • 08/25/23